Novel Candidate <i>loci</i> and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing

The familial occurrence of hematological malignancies has been underappreciated. Recent studies suggest that up to 15% of adults with myeloid neoplasms carry germline pathogenic variants in cancer-predisposing genes. This study aimed to identify the underlying germline predisposition variant in pati...

Full description

Bibliographic Details
Main Authors: Cristina Andrés-Zayas, Julia Suárez-González, María Chicano-Lavilla, Mariana Bastos Oreiro, Gabriela Rodríguez-Macías, Patricia Font López, Santiago Osorio Prendes, Gillen Oarbeascoa Royuela, Patricia García Ramírez, Rocío Nieves Salgado, Ignacio Gómez-Centurión, Diego Carbonell Muñoz, Paula Muñiz, Mi Kwon, José Luis Díez-Martín, Ismael Buño, Carolina Martínez-Laperche
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/3/944
_version_ 1797624937093005312
author Cristina Andrés-Zayas
Julia Suárez-González
María Chicano-Lavilla
Mariana Bastos Oreiro
Gabriela Rodríguez-Macías
Patricia Font López
Santiago Osorio Prendes
Gillen Oarbeascoa Royuela
Patricia García Ramírez
Rocío Nieves Salgado
Ignacio Gómez-Centurión
Diego Carbonell Muñoz
Paula Muñiz
Mi Kwon
José Luis Díez-Martín
Ismael Buño
Carolina Martínez-Laperche
author_facet Cristina Andrés-Zayas
Julia Suárez-González
María Chicano-Lavilla
Mariana Bastos Oreiro
Gabriela Rodríguez-Macías
Patricia Font López
Santiago Osorio Prendes
Gillen Oarbeascoa Royuela
Patricia García Ramírez
Rocío Nieves Salgado
Ignacio Gómez-Centurión
Diego Carbonell Muñoz
Paula Muñiz
Mi Kwon
José Luis Díez-Martín
Ismael Buño
Carolina Martínez-Laperche
author_sort Cristina Andrés-Zayas
collection DOAJ
description The familial occurrence of hematological malignancies has been underappreciated. Recent studies suggest that up to 15% of adults with myeloid neoplasms carry germline pathogenic variants in cancer-predisposing genes. This study aimed to identify the underlying germline predisposition variant in patients with a strong family or personal onco-hematological history using whole exome sequencing on sixteen uncharacterized individuals. It was carried out in two groups of patients, one with samples available from two affected relatives (Cohort A) and one with available samples from the index case (Cohort B). In Cohort A, six families were characterized. Two families shared variants in genes associated with DNA damage response and involved in cancer development (<i>CHEK2</i> and <i>RAD54L</i>). Pathogenic or likely pathogenic germline variants were also found in novel candidate genes (<i>NFATC2</i> and <i>TC2N</i>). In two families, any relevant pathogenic or likely pathogenic genomic variants were identified. In Cohort B, four additional index cases were analyzed. Three of them harbor clinically relevant variants in genes with a probable role in the development of inherited forms of hematological malignancies (<i>GATA1</i>, <i>MSH4</i> and <i>PRF1</i>). Overall, whole exome sequencing is a useful approach to achieve a further characterization of these patients and their mutational spectra. Moreover, further investigations may help improve optimization for disease management of affected patients and their families.
first_indexed 2024-03-11T09:49:43Z
format Article
id doaj.art-07220a09b616478199925ae2643143c1
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T09:49:43Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-07220a09b616478199925ae2643143c12023-11-16T16:19:28ZengMDPI AGCancers2072-66942023-02-0115394410.3390/cancers15030944Novel Candidate <i>loci</i> and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome SequencingCristina Andrés-Zayas0Julia Suárez-González1María Chicano-Lavilla2Mariana Bastos Oreiro3Gabriela Rodríguez-Macías4Patricia Font López5Santiago Osorio Prendes6Gillen Oarbeascoa Royuela7Patricia García Ramírez8Rocío Nieves Salgado9Ignacio Gómez-Centurión10Diego Carbonell Muñoz11Paula Muñiz12Mi Kwon13José Luis Díez-Martín14Ismael Buño15Carolina Martínez-Laperche16Genomics Unit, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), 28009 Madrid, SpainGenomics Unit, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), 28009 Madrid, SpainGregorio Marañón Health Research Institute (IiSGM), 28009 Madrid, SpainGregorio Marañón Health Research Institute (IiSGM), 28009 Madrid, SpainDepartment of Hematology, Gregorio Marañón General University Hospital, 28007 Madrid, SpainDepartment of Hematology, Gregorio Marañón General University Hospital, 28007 Madrid, SpainDepartment of Hematology, Gregorio Marañón General University Hospital, 28007 Madrid, SpainGregorio Marañón Health Research Institute (IiSGM), 28009 Madrid, SpainDepartment of Hematology, Hospital Universitario Príncipe de Asturias, 28802 Madrid, SpainDepartment of Hematology, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, SpainGregorio Marañón Health Research Institute (IiSGM), 28009 Madrid, SpainGregorio Marañón Health Research Institute (IiSGM), 28009 Madrid, SpainGregorio Marañón Health Research Institute (IiSGM), 28009 Madrid, SpainGregorio Marañón Health Research Institute (IiSGM), 28009 Madrid, SpainGregorio Marañón Health Research Institute (IiSGM), 28009 Madrid, SpainGenomics Unit, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), 28009 Madrid, SpainGregorio Marañón Health Research Institute (IiSGM), 28009 Madrid, SpainThe familial occurrence of hematological malignancies has been underappreciated. Recent studies suggest that up to 15% of adults with myeloid neoplasms carry germline pathogenic variants in cancer-predisposing genes. This study aimed to identify the underlying germline predisposition variant in patients with a strong family or personal onco-hematological history using whole exome sequencing on sixteen uncharacterized individuals. It was carried out in two groups of patients, one with samples available from two affected relatives (Cohort A) and one with available samples from the index case (Cohort B). In Cohort A, six families were characterized. Two families shared variants in genes associated with DNA damage response and involved in cancer development (<i>CHEK2</i> and <i>RAD54L</i>). Pathogenic or likely pathogenic germline variants were also found in novel candidate genes (<i>NFATC2</i> and <i>TC2N</i>). In two families, any relevant pathogenic or likely pathogenic genomic variants were identified. In Cohort B, four additional index cases were analyzed. Three of them harbor clinically relevant variants in genes with a probable role in the development of inherited forms of hematological malignancies (<i>GATA1</i>, <i>MSH4</i> and <i>PRF1</i>). Overall, whole exome sequencing is a useful approach to achieve a further characterization of these patients and their mutational spectra. Moreover, further investigations may help improve optimization for disease management of affected patients and their families.https://www.mdpi.com/2072-6694/15/3/944predisposition syndromeswhole-exome sequencingcancer susceptibilityhematological malignanciesgermline mutation
spellingShingle Cristina Andrés-Zayas
Julia Suárez-González
María Chicano-Lavilla
Mariana Bastos Oreiro
Gabriela Rodríguez-Macías
Patricia Font López
Santiago Osorio Prendes
Gillen Oarbeascoa Royuela
Patricia García Ramírez
Rocío Nieves Salgado
Ignacio Gómez-Centurión
Diego Carbonell Muñoz
Paula Muñiz
Mi Kwon
José Luis Díez-Martín
Ismael Buño
Carolina Martínez-Laperche
Novel Candidate <i>loci</i> and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing
Cancers
predisposition syndromes
whole-exome sequencing
cancer susceptibility
hematological malignancies
germline mutation
title Novel Candidate <i>loci</i> and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing
title_full Novel Candidate <i>loci</i> and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing
title_fullStr Novel Candidate <i>loci</i> and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing
title_full_unstemmed Novel Candidate <i>loci</i> and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing
title_short Novel Candidate <i>loci</i> and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing
title_sort novel candidate i loci i and pathogenic germline variants involved in familial hematological malignancies revealed by whole exome sequencing
topic predisposition syndromes
whole-exome sequencing
cancer susceptibility
hematological malignancies
germline mutation
url https://www.mdpi.com/2072-6694/15/3/944
work_keys_str_mv AT cristinaandreszayas novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT juliasuarezgonzalez novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT mariachicanolavilla novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT marianabastosoreiro novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT gabrielarodriguezmacias novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT patriciafontlopez novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT santiagoosorioprendes novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT gillenoarbeascoaroyuela novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT patriciagarciaramirez novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT rocionievessalgado novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT ignaciogomezcenturion novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT diegocarbonellmunoz novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT paulamuniz novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT mikwon novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT joseluisdiezmartin novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT ismaelbuno novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing
AT carolinamartinezlaperche novelcandidateilociiandpathogenicgermlinevariantsinvolvedinfamilialhematologicalmalignanciesrevealedbywholeexomesequencing